This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
In the April–June 2015 edition of Corporate Disputes, Dr. Gregory Bell and Professor Iain Cockburn discuss damages in the pharmaceutical and biotech sector . To read more, click on the link below.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comSeveral pivotal topics emerged, establishing predominant themes throughout the conference. Although efficacy continues to be the fundamental basis of oncology...
The relationship between ASP dynamics and changes to WAC, both publicly available, offers insight into the apparent level of price concessions for a product....
Is Going to a Private-Equity Owned Hospital Bad for Your Health? Private equity investment in health care has increased more than 20-fold—from $5 billion in...
Erin McDermott moderates the session exploring practical strategies for balancing caregiving responsibilities with professional goals. Caring for a parent,...
